Topical application of a novel, hydrophilic gamma-tocopherol derivative reduces photo-inflammation in mice skin

J Invest Dermatol. 2006 Jul;126(7):1633-40. doi: 10.1038/sj.jid.5700236. Epub 2006 Mar 16.

Abstract

We previously demonstrated that a novel hydrophilic gamma-tocopherol (gamma-Toc) derivative, gamma-tocopherol-N,N-dimethylglycinate hydrochloride (gamma-TDMG) converts to gamma-Toc in the mouse skin and has a higher bioavailability than gamma-Toc itself. In the present study, we determined whether gamma-TDMG could reduce photo-inflammation in mouse skin, and compared its effectiveness to that of alpha-Toc acetate (alpha-TA). Topical pre- or post-application of 5% gamma-TDMG significantly reduced the formation of edema and tempered the increase in cyclooxygenase-2 (COX-2)-catalyzed synthesis of prostaglandin E2 (PGE2) that were induced by a single dose of UV irradiation of 2 kJ/m2 (290-380 nm, maximum 312 nm). The pre-treatment of mouse skin with 10% alpha-TA had the same anti-inflammatory effect as did gamma-TDMG. In spite of same having the ability to reduce PGE2 levels, the effect of gamma-TDMG pre-treatment on the inhibition of COX-2 mRNA/protein expression was less than that seen with 10% alpha-TA. In contrast, the increase in COX-2 activity seen after UV exposure was reduced more by gamma-TDMG than by alpha-TA, suggesting that the reduction in PGE2 levels might have been due to the direct inhibition of COX-2 activity by gamma-TDMG-derived gamma-Toc. Both Toc derivatives strongly suppressed inducible nitric oxide synthase (iNOS) mRNA expression and nitric oxide (NO) production, both of which play important roles in UV-induced inflammation. Both derivatives also significantly reduced lipid peroxidation in response to UV exposure, though gamma-TDMG's ability in this regard was less than that seen with alpha-TA, which correlated with their abilities to suppress COX-2 expression. Thus, the gamma-TDMG-derived gamma-Toc acts as an antioxidant, suppresses iNOS expression and directly inhibits COX-2 activity, all of which likely play a role in mediating its suppressive effects on photo-inflammation. Our data further suggest that the topical application of gamma-TDMG, a novel hydrophilic gamma-Toc derivative, may be efficacious in preventing and reducing UV-induced inflammation in humans.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology*
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Dinoprostone / metabolism
  • Epidermis / chemistry
  • Epidermis / pathology
  • Epidermis / physiopathology
  • Epidermis / radiation effects*
  • Female
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / radiation effects
  • Glycine / administration & dosage
  • Glycine / analogs & derivatives*
  • Glycine / pharmacology
  • Indomethacin / pharmacology
  • Inflammation / drug therapy*
  • Inflammation / etiology*
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / radiation effects
  • Mice
  • Mice, Hairless
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • RNA, Messenger / analysis
  • Reactive Oxygen Species / metabolism
  • Tocopherols
  • Ultraviolet Rays / adverse effects
  • alpha-Tocopherol / administration & dosage
  • alpha-Tocopherol / analogs & derivatives
  • alpha-Tocopherol / analysis
  • alpha-Tocopherol / pharmacology
  • gamma-Tocopherol / administration & dosage
  • gamma-Tocopherol / analogs & derivatives*
  • gamma-Tocopherol / pharmacology*

Substances

  • Antioxidants
  • Cyclooxygenase Inhibitors
  • RNA, Messenger
  • Reactive Oxygen Species
  • gamma-tocopherol-N,N-dimethylglycinate hydrochloride
  • Nitric Oxide
  • gamma-Tocopherol
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Cyclooxygenase 2
  • alpha-Tocopherol
  • Dinoprostone
  • Tocopherols
  • Glycine
  • Indomethacin